BIOSPECIFICS TECHNOLOGIES CORP

• Accepted (ET)
• Feb 16SC 13G/A—
  BIOSPECIFICS TECHNOLOGIES CORP0001172661-21-000457 · 54.2 KB
  SEC(opens sec.gov)
• Feb 10SC 13G/A—
  BIOSPECIFICS TECHNOLOGIES CORP0001037389-21-000075 · 13.2 KB
  SEC(opens sec.gov)
• Dec 3SC 13D/A—
  BIOSPECIFICS TECHNOLOGIES CORP0001193125-20-309778 · 76.8 KB
  SEC(opens sec.gov)
• Dec 2SC 13D/A—
  BIOSPECIFICS TECHNOLOGIES CORP0001193125-20-307970 · 63.5 KB
  SEC(opens sec.gov)
• Dec 28-K—
  Current report0001193125-20-307955 · 386.7 KB
  SEC(opens sec.gov)
• Nov 910-Q—
  Quarterly update0001558370-20-013305 · 5.9 MB
  SEC(opens sec.gov)
• Nov 98-K—
  Current report0001193125-20-288539 · 270.2 KB
  SEC(opens sec.gov)
• Oct 29SC 13D—
  BIOSPECIFICS TECHNOLOGIES CORP0001193125-20-281266 · 155.1 KB
  SEC(opens sec.gov)
• Oct 29SC 13D—
  BIOSPECIFICS TECHNOLOGIES CORP0001193125-20-281203 · 145.7 KB
  SEC(opens sec.gov)
• Oct 198-K—
  Current report0001193125-20-271739 · 910.5 KB
  SEC(opens sec.gov)

• BIO PARTNERS LP10% Owner
• BUCHI J KEVINDirector, Chief Executive Officer
• CALDWELL PATRICK MPrincipal Financial Officer
• Chao Jennifer MDirector
• Dobroff LawrenceCFO
• Endo International plc10% Owner
• Estate of Edwin H. Wegman10% Owner
• Fishman Corey N.Director
• Geller MatthewDirector
• Gitman PaulDirector

No tickers on record.

• business

  35 WILBUR ST

  LYNBROOK, NY, 11563

• mailing

  2 RIGHTER PARKWAY, SUITE 200

  WILMINGTON, DE, 19803